Emerging Company Profile By Kathryn Calkins
Staff Writer

In the race to quicken the pace and success rate of drug discovery, a critical bottleneck is drug selection. NaviCyte Inc. believes that it can add value and efficiency to the discovery process by providing an alternative to drug bioavailability studies in animals and by creating software models that predict the bioavailability of compounds in humans.